Adaptimmune Therapeutics shares owned by Baillie Gifford & Co
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Baillie Gifford & Co
from 13F filings
Historical chart of Baillie Gifford & Co investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Baillie Gifford & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Baillie Gifford & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $16M | 17M | 0.95 |
| 2024-06-30 | $15M | 15M | 0.97 |
| 2024-03-31 | $25M | 16M | 1.58 |
| 2023-12-31 | $13M | 16M | 0.79 |
| 2023-09-30 | $13M | 17M | 0.78 |
| 2023-06-30 | $16M | 17M | 0.93 |
| 2023-03-31 | $19M | 17M | 1.09 |
| 2022-12-31 | $25M | 17M | 1.46 |
| 2022-09-30 | $16M | 15M | 1.08 |
| 2022-06-30 | $26M | 15M | 1.70 |
| 2022-03-31 | $32M | 15M | 2.06 |
| 2021-12-31 | $52M | 14M | 3.75 |
| 2021-09-30 | $66M | 13M | 5.17 |
| 2021-06-30 | $50M | 12M | 4.26 |
| 2021-03-31 | $61M | 12M | 5.31 |
| 2020-12-31 | $56M | 10M | 5.39 |
| 2020-09-30 | $57M | 7.1M | 7.98 |
| 2020-06-30 | $53M | 5.3M | 10.01 |
| 2020-03-31 | $12M | 4.4M | 2.72 |
| 2019-12-31 | $5.1M | 4.3M | 1.20 |
| 2019-09-30 | $6.3M | 4.2M | 1.51 |
| 2019-06-30 | $17M | 4.1M | 4.02 |
| 2019-03-31 | $17M | 3.8M | 4.30 |
| 2018-12-31 | $21M | 3.7M | 5.75 |
| 2018-09-30 | $46M | 3.4M | 13.56 |
| 2018-06-30 | $36M | 3.0M | 11.87 |
| 2018-03-31 | $29M | 2.6M | 11.23 |
| 2017-12-31 | $13M | 1.9M | 6.68 |
| 2017-09-30 | $11M | 1.4M | 8.19 |
| 2017-06-30 | $5.9M | 1.3M | 4.49 |
| 2017-03-31 | $5.1M | 921k | 5.51 |
| 2016-12-31 | $3.7M | 921k | 4.05 |
| 2016-09-30 | $6.5M | 921k | 7.05 |
| 2016-06-30 | $3.5M | 430k | 8.15 |
| 2016-03-31 | $3.5M | 430k | 8.13 |